Rapid assessment of avoidable blindness in Papua New Guinea: a nationwide survey.


Journal

The British journal of ophthalmology
ISSN: 1468-2079
Titre abrégé: Br J Ophthalmol
Pays: England
ID NLM: 0421041

Informations de publication

Date de publication:
03 2019
Historique:
received: 26 12 2017
revised: 03 04 2018
accepted: 24 04 2018
pubmed: 26 5 2018
medline: 28 10 2019
entrez: 26 5 2018
Statut: ppublish

Résumé

To estimate the prevalence and main causes of blindness and vision impairment in people aged 50 years and older in Papua New Guinea (PNG). National cross-sectional population-based survey in National Capital District (NCD), Highlands, Coastal and Islands regions. Adults aged 50 years and above were recruited from 100 randomly selected clusters. Each participant underwent monocular presenting and pinhole visual acuity (VA) assessment and lens examination. Those with pinhole VA<6/12 in either eye had a dilated fundus examination to determine the primary cause of reduced vision. Those with obvious lens opacity were interviewed on barriers to cataract surgery. A total of 4818 adults were examined. The age-adjusted and sex-adjusted prevalence of blindness (VA <3/60), severe vision impairment (SVI, VA <6/60 but ≥3/60), moderate vision impairment (MVI, VA <6/18 but ≥6/60) and early vision impairment (EVI, VA <6/12 but ≥6/18) was 5.6% (95% CI 4.9% to 6.3%), 2.9% (95% CI 2.5% to 3.4%), 10.9% (95% CI 9.9% to 11.9%) and 7.3% (95% CI 6.6% to 8.0%), respectively. The main cause of blindness, SVI and MVI was cataract, while uncorrected refractive error was the main cause of EVI. A significantly higher prevalence of blindness, SVI and MVI occurred in the Highlands compared with NCD. Across all regions, women had lower cataract surgical coverage and spectacle coverage than men. PNG has one of the highest reported prevalence of blindness globally. Cataract and uncorrected refractive error are the main causes, suggesting a need for increased accessible services with improved resources and advocacy for enhancing eye health literacy.

Identifiants

pubmed: 29793925
pii: bjophthalmol-2017-311802
doi: 10.1136/bjophthalmol-2017-311802
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

338-342

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Ling Lee (L)

Brien Holden Vision Institute, Sydney, New South Wales, Australia l.lee@brienholdenvision.org.
School of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia.

Fabrizio D'Esposito (F)

Knowledge and Innovation Division, The Fred Hollows Foundation, Melbourne, Victoria, Australia.

Jambi Garap (J)

PNG Eye Care, National Capital District, Papua New Guinea.
PNG National Prevention of Blindness Committee, National Capital District, National Capital District, Papua New Guinea.

Geoffrey Wabulembo (G)

School of Medical and Health Sciences, University of Papua New Guinea, National Capital District, Papua New Guinea.
CBM International, National Capital District, Papua New Guinea.

Samuel Peter Koim (SP)

PNG Eye Care, National Capital District, Papua New Guinea.
PNG National Prevention of Blindness Committee, National Capital District, National Capital District, Papua New Guinea.

Drew Keys (D)

Brien Holden Vision Institute, Sydney, New South Wales, Australia.
PNG Eye Care, National Capital District, Papua New Guinea.
PNG National Prevention of Blindness Committee, National Capital District, National Capital District, Papua New Guinea.
International Agency for the Prevention of Blindness, London, UK.

Anaseini T Cama (AT)

Pacific Trachoma Initiative, The Fred Hollows Foundation, Sydney, New South Wales, Australia.

Hans Limburg (H)

Health Information Services, Grootebroek, The Netherlands.

Anthea Burnett (A)

Brien Holden Vision Institute, Sydney, New South Wales, Australia.
School of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH